查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1306106

人類乳突病毒檢測市場：按產品、最終用戶、用途- 俄羅斯-烏克蘭衝突、高通貨膨脹的累積影響 - 2023-2030 年全球預測

Human Papillomavirus Testing Market by Product, End-User, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球人類乳突病毒檢測市場預計將以 13.56% 的複合年成長率大幅成長，到 2023 年達到 11.148 億美元，到 2030 年將達到 27.1863 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球人類乳突病毒檢測市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 人類乳突病毒檢測的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球人類乳突病毒檢測市場的抑制要素和影響是什麼？

3.在預測期內，全球人類乳突病毒檢測市場需要投資哪些產品/細分市場/應用/領域？

4. 全球人類乳突病毒檢測市場的競爭策略是什麼？

5. 全球人類乳突病毒檢測市場的技術趨勢和法律規範是什麼？

6.全球人類乳突病毒檢測市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球人類乳突病毒檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 宮頸癌患者數量增加和人口高齡化
      • 提高對宮頸癌篩查計劃的認知
      • 政府舉措和資金
    • 抑制因素
      • 不提供男性 HPV 檢測
    • 機會
      • HPV初篩檢測簡介
      • HPV 聯合檢測的需求不斷增加
    • 任務
      • 不確定的贖回場景
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 人類乳突病毒檢測市場：副產品

  • 消耗品
  • 系統

第7章 人類乳突病毒檢測市場：按最終用戶分類

  • 臨床診斷實驗室
  • 醫院
  • 醫生辦公室

第8章 人類乳突病毒檢測市場：按用途

  • 生物感測器
  • 染色體分析
  • 流式細胞術
  • 免疫學測試
  • 微陣列
  • 分子診斷
  • 單克隆和多克隆抗體

第9章 美洲人類乳突病毒檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太人類乳突病毒檢測市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲人類乳突病毒檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-43127F7278E3

The Global Human Papillomavirus Testing Market is forecasted to grow significantly, with a projected USD 1,114.80 million in 2023 at a CAGR of 13.56% and expected to reach a staggering USD 2,718.63 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Papillomavirus Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Papillomavirus Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Systems. The Systems is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinical Diagnostic Laboratories, Hospitals, and Physicians' Office Laboratories. The Hospitals is projected to witness significant market share during forecast period.

Based on Application, market is studied across Biosensors, Chromosome Analysis, Flow Cytometry, Immunoassays, Microarrays, Molecular Diagnostics, and Monoclonal & Polyclonal Antibodies. The Flow Cytometry is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Papillomavirus Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Papillomavirus Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Papillomavirus Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Papillomavirus Testing Market?

4. What is the competitive strategic window for opportunities in the Global Human Papillomavirus Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Human Papillomavirus Testing Market?

6. What is the market share of the leading vendors in the Global Human Papillomavirus Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Papillomavirus Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Human Papillomavirus Testing Market, by Product, 2022 vs 2030
  • 4.3. Human Papillomavirus Testing Market, by End-User, 2022 vs 2030
  • 4.4. Human Papillomavirus Testing Market, by Application, 2022 vs 2030
  • 4.5. Human Papillomavirus Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of cervical cancer cases and growing aging population
      • 5.1.1.2. Growing awareness of cervical cancer screening programs
      • 5.1.1.3. Government initiatives and funding
    • 5.1.2. Restraints
      • 5.1.2.1. Non-availability of HPV test for men
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of HPV primary screening tests
      • 5.1.3.2. Increasing Demand for HPV Co-testing
    • 5.1.4. Challenges
      • 5.1.4.1. Uncertain reimbursement scenario
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Human Papillomavirus Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Systems

7. Human Papillomavirus Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Diagnostic Laboratories
  • 7.3. Hospitals
  • 7.4. Physicians' Office Laboratories

8. Human Papillomavirus Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Biosensors
  • 8.3. Chromosome Analysis
  • 8.4. Flow Cytometry
  • 8.5. Immunoassays
  • 8.6. Microarrays
  • 8.7. Molecular Diagnostics
  • 8.8. Monoclonal & Polyclonal Antibodies

9. Americas Human Papillomavirus Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Papillomavirus Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Papillomavirus Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HUMAN PAPILLOMAVIRUS TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. HUMAN PAPILLOMAVIRUS TESTING MARKET DYNAMICS
  • FIGURE 9. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. HUMAN PAPILLOMAVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. HUMAN PAPILLOMAVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HUMAN PAPILLOMAVIRUS TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 8. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PHYSICIANS' OFFICE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY CHROMOSOME ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HUMAN PAPILLOMAVIRUS TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. HUMAN PAPILLOMAVIRUS TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. HUMAN PAPILLOMAVIRUS TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. HUMAN PAPILLOMAVIRUS TESTING MARKET LICENSE & PRICING